These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26440098)

  • 1. Expansion of polyalanine tracts in the QA domain may play a critical role in the clavicular development of cleidocranial dysplasia.
    Wu LZ; Xu XY; Liu YF; Ge X; Wang XJ
    J Genet; 2015 Sep; 94(3):551-3. PubMed ID: 26440098
    [No Abstract]   [Full Text] [Related]  

  • 2. Biology of RUNX2 and Cleidocranial Dysplasia.
    Cohen MM
    J Craniofac Surg; 2013 Jan; 24(1):130-3. PubMed ID: 23348269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cleidocranial dysplasia-related R131G mutation in the Runt-related transcription factor RUNX2 disrupts binding to DNA but not CBF-beta.
    Han MS; Kim HJ; Wee HJ; Lim KE; Park NR; Bae SC; van Wijnen AJ; Stein JL; Lian JB; Stein GS; Choi JY
    J Cell Biochem; 2010 May; 110(1):97-103. PubMed ID: 20225274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleidocranial dysostosis.
    Back SJ; Pollock AN
    Pediatr Emerg Care; 2013 Jul; 29(7):867-9. PubMed ID: 23823271
    [No Abstract]   [Full Text] [Related]  

  • 5. Four novel RUNX2 mutations including a splice donor site result in the cleidocranial dysplasia phenotype.
    Kim HJ; Nam SH; Kim HJ; Park HS; Ryoo HM; Kim SY; Cho TJ; Kim SG; Bae SC; Kim IS; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Choi JY
    J Cell Physiol; 2006 Apr; 207(1):114-22. PubMed ID: 16270353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleidocranial dysplasia with severe parietal bone dysplasia: C-terminal RUNX2 mutations.
    Cunningham ML; Seto ML; Hing AV; Bull MJ; Hopkin RJ; Leppig KA
    Birth Defects Res A Clin Mol Teratol; 2006 Feb; 76(2):78-85. PubMed ID: 16463420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cleidocranial dysplasia in a Polish population: high frequency of the R193X mutation.
    Kisiel BM; Kostrzewa G; Wlasienko P; Kruczek A; Gajdulewicz M; Maciejak D; Wisniewska M; Ploski R; Korniszewski L
    Clin Genet; 2006 Aug; 70(2):167-9. PubMed ID: 16879201
    [No Abstract]   [Full Text] [Related]  

  • 8. Cleidocranial dysplasia: Clinical, endocrinologic and molecular findings in 15 patients from 11 families.
    Dinçsoy Bir F; Dinçkan N; Güven Y; Baş F; Altunoğlu U; Kuvvetli SS; Poyrazoğlu Ş; Toksoy G; Kayserili H; Uyguner ZO
    Eur J Med Genet; 2017 Mar; 60(3):163-168. PubMed ID: 28027977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and molecular study in a family with cleidocranial dysplasia].
    Callea M; Fattori F; Bertini ES; Yavuz I; Bellacchio E; Avendaño A; Araque D; Lacruz-Rengel MA; Da Silva G; Cammarata-Scalisi F
    Arch Argent Pediatr; 2017 Dec; 115(6):e440-e444. PubMed ID: 29087131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleidocranial dysplasia and RUNX2-clinical phenotype-genotype correlation.
    Jaruga A; Hordyjewska E; Kandzierski G; Tylzanowski P
    Clin Genet; 2016 Nov; 90(5):393-402. PubMed ID: 27272193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel RUNX2 mutation in exon 8, G462X, in a patient with Cleidocranial Dysplasia.
    Jung YJ; Bae HS; Ryoo HM; Baek SH
    J Cell Biochem; 2018 Jan; 119(1):1152-1162. PubMed ID: 28703881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical cleidocranial dysplasia in an adult, due to a novel frameshift pathogenic variant in RUNX2.
    Hebbar M; Girisha KM; Shukla A
    BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27177937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clarification of data reported in "cleidocranial dysplasia: molecular genetic analysis and phenotypic-based description of a Middle European patient group" (AJMG 139A:78-85).
    Baumert U; Golan I; Redlich M; Aknin JJ; Muessig D
    Am J Med Genet A; 2006 May; 140(9):1030. PubMed ID: 16575894
    [No Abstract]   [Full Text] [Related]  

  • 14. Cleidocranial dysplasia plus vascular anomalies with 6p21.2 microdeletion spanning RUNX2 and VEGF.
    Izumi K; Yahagi N; Fujii Y; Higuchi M; Kosaki R; Naito Y; Nishimura G; Hosokai N; Takahashi T; Kosaki K
    Am J Med Genet A; 2006 Feb; 140(4):398-401. PubMed ID: 16419134
    [No Abstract]   [Full Text] [Related]  

  • 15. RUNX2 analysis of Danish cleidocranial dysplasia families.
    Hansen L; Riis AK; Silahtaroglu A; Hove H; Lauridsen E; Eiberg H; Kreiborg S
    Clin Genet; 2011 Mar; 79(3):254-63. PubMed ID: 20560987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pierre Marie-Sainton cleidocranial dysplasia].
    Diaconescu S; Păduraru G; Vâscu AM; Burlea M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):341-8. PubMed ID: 21870721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ehlers-Danlos syndrome versus cleidocranial dysplasia.
    Bedeschi MF; Bonarrigo F; Manzoni F; Milani D; Piemontese MR; Guez S; Esposito S
    Ital J Pediatr; 2014 May; 40():49. PubMed ID: 24887404
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel 18-bp in-frame deletion mutation in RUNX2 causes cleidocranial dysplasia.
    Zeng L; Wei J; Zhao N; Sun S; Wang Y; Feng H
    Arch Oral Biol; 2018 Dec; 96():243-248. PubMed ID: 29089101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive cognitive decline in an adult patient with cleidocranial dysplasia.
    Takenouchi T; Sato W; Torii C; Kosaki K
    Eur J Med Genet; 2014 Jul; 57(7):319-21. PubMed ID: 24797831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia.
    Mundlos S; Otto F; Mundlos C; Mulliken JB; Aylsworth AS; Albright S; Lindhout D; Cole WG; Henn W; Knoll JH; Owen MJ; Mertelsmann R; Zabel BU; Olsen BR
    Cell; 1997 May; 89(5):773-9. PubMed ID: 9182765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.